Dianthus Therapeutics, Inc. (DNTH)

NASDAQ: DNTH · IEX Real-Time Price · USD

21.50

+0.51 (2.43%)

At close: Apr 26, 2024, 4:00 PM

20.57

-0.93 (-4.33%)

After-hours: Apr 26, 2024, 7:38 PM EDT

Dianthus Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	631	154	24	260	379	591	189
Market Cap Growth	-	544.27%	-90.81%	-31.24%	-35.93%	212.80%	-
Enterprise Value	458	-19	-51	82	228	444	45
PE Ratio	-3.54	-3.54	-0.84	-3.66	-5.05	-7.70	-3.28
PS Ratio	223.27	54.53	3.73	-	-	-	-
PB Ratio	3.74	0.91	-0.54	1.51	2.63	4.19	1.30
P/FCF Ratio	-4.17	-4.17	-0.82	-4.28	-5.88	-9.82	-3.81
P/OCF Ratio	-4.18	-4.18	-0.82	-4.37	-5.92	-10.35	-4.51
EV/Sales Ratio	162.00	-6.73	-7.91	-	-	-	-
EV/EBITDA Ratio	0.44	0.44	1.79	-1.18	-3.13	-5.92	-0.79
EV/EBIT Ratio	0.44	0.44	1.78	-1.15	-3.04	-5.78	-0.78
EV/FCF Ratio	0.51	0.51	1.74	-1.34	-3.54	-7.37	-0.90
Debt / Equity Ratio	0.00	0.00	-0.02	-	-	-	-
Debt / EBITDA Ratio	-0.01	-0.01	-0.03	-	-	-	-
Debt / FCF Ratio	-0.02	-0.02	-0.03	-	-	-	-
Quick Ratio	18.09	18.09	9.86	16.45	13.18	10.45	13.85
Current Ratio	18.43	18.43	9.97	16.63	13.26	10.62	13.95
Asset Turnover	0.02	0.02	0.04	0	0	0	0
Return on Equity (ROE)	-34.90%	-34.90%	-31.10%	-41.00%	-49.80%	-49.80%	-111.30%
Return on Assets (ROA)	-32.60%	-32.60%	-18.50%	-37.40%	-44.60%	-45.00%	-54.40%
Return on Capital (ROIC)	-28.43%	-28.43%	68.16%	-43.26%	-54.69%	-58.76%	-41.17%
Earnings Yield	-6.90%	-28.26%	-119.05%	-27.32%	-19.79%	-12.99%	-30.48%
FCF Yield	-5.86%	-23.99%	-122.11%	-23.35%	-17.01%	-10.18%	-26.22%
Buyback Yield / Dilution	-489.48%	-489.48%	74.54%	-25.11%	-18.66%	-101.28%	-890.33%
Total Shareholder Return	-489.48%	-489.48%	74.54%	-25.11%	-18.66%	-101.28%	-890.33%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).